3.20
Orchestra Biomed Holdings Inc Aktie (OBIO) Neueste Nachrichten
Is Orchestra BioMed Holdings Inc. a good long term investmentPowerful growth strategies - Autocar Professional
What drives Orchestra BioMed Holdings Inc. stock priceFree Advanced Stock Screener Access - Autocar Professional
Orchestra BioMed Holdings Inc. Stock Analysis and ForecastBreakthrough stock performance - Autocar Professional
What analysts say about Orchestra BioMed Holdings Inc. stockRapid market gains - jammulinksnews.com
Why Orchestra BioMed Holdings Inc. stock attracts strong analyst attentionFree Predictions - Newser
How Orchestra BioMed Holdings Inc. stock performs during market volatilityDouble Your Capital Alerts - Newser
What makes Orchestra BioMed Holdings Inc. stock price move sharplyMinimized Risk Trading Plan - Newser
How To Trade (OBIO) - news.stocktradersdaily.com
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Given Consensus Rating of “Buy” by Brokerages - Defense World
Orchestra BioMed (NASDAQ:OBIO) Trading Up 1.7% – Here’s What Happened - Defense World
Orchestra BioMed Secures FDA Clearance for Virtue Trial to Advance Coronary ISR Treatment - MSN
Orchestra BioMed to Present at Jefferies Global Healthcare Conference - MSN
Hedge funds owners may take dramatic actions as Orchestra BioMed Holdings, Inc.'s (NASDAQ:OBIO) recent 14% drop adds to one-year losses - simplywall.st
Learn to Evaluate (OBIO) using the Charts - news.stocktradersdaily.com
Orchestra BioMed: A Contrarian Gem in the Biotech Doldrums - AInvest
Orchestra BioMed Holdings, Inc.(NasdaqGM:OBIO) dropped from Russell Small Cap Comp Value Index - MarketScreener
Orchestra BioMed Confirms Director Elections and Auditor - TipRanks
Orchestra BioMed Showcases AVIM Therapy as Purpose-Built - GlobeNewswire
Millennium Management LLC Makes New Investment in Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) - Defense World
Citadel Advisors LLC Sells 7,836 Shares of Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) - Defense World
(OBIO) Trading Advice - news.stocktradersdaily.com
Orchestra Biomed Reports Increased Losses Amid Revenue Growth - TipRanks
B. Riley Cuts Price Target on Orchestra BioMed Holdings to $12 From $15, Keeps Buy Rating - marketscreener.com
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Stake Increased by Northern Trust Corp - Defense World
Orchestra BioMed: Two Best-In-Class Devices And Promising Partnerships - Seeking Alpha
Orchestra BioMed Reports Q1 2025 Financial Results and Advances Key Clinical Programs - MSN
The Manufacturers Life Insurance Company Raises Position in Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) - Defense World
FY2026 Earnings Estimate for OBIO Issued By Chardan Capital - Defense World
Orchestra BioMed Expands Patent Portfolio for AVIM Therapy, Gains FDA Breakthrough Designation - MSN
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):